-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
scPharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
- scPharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$18.1M, a 22.3% decline year-over-year.
- scPharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$63.7M, a 28.3% decline year-over-year.
- scPharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$55.4M, a 53.2% decline from 2022.
- scPharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$36.2M, a 40% decline from 2021.
- scPharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$25.8M, a 13.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)